Koers Steris PLC Nyse
Aandelen
GB00BVVBC028
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 5,46 mld. 5,11 mld. | Omzet 2025 * | 5,73 mld. 5,35 mld. | Marktkapitalisatie | 20,15 mld. 18,84 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 544 mln. 509 mln. | Nettowinst (verlies) 2025 * | 641 mln. 600 mln. | EV/omzet 2024 * | 4,23 x |
Nettoschuld 2024 * | 2,94 mld. 2,75 mld. | Nettoschuld 2025 * | 2,41 mld. 2,26 mld. | EV/omzet 2025 * | 3,94 x |
K/w-verhouding 2024 * |
37,2
x | K/w-verhouding 2025 * |
30,2
x | Werknemers | - |
Dividendrendement 2024 * |
1% | Dividendrendement 2025 * |
1,09% | Vrij verhandelbaar | 99,73% |
Recentste transcriptie over Steris PLC
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Carestio
CEO | Chief Executive Officer | 51 | 01-08-18 |
Michael Tokich
DFI | Director of Finance/CFO | 56 | 01-02-14 |
Julie Winter
IRC | Investor Relations Contact | - | 01-05-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Breeden
BRD | Director/Board Member | 74 | 01-04-08 |
Director/Board Member | 74 | 01-10-03 | |
Director/Board Member | 58 | 28-07-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 187 mld. | |
-3,20% | 106 mld. | |
-5,04% | 66,9 mld. | |
+0,20% | 49,45 mld. | |
+17,29% | 48 mld. | |
+4,06% | 40,84 mld. | |
+2,07% | 26,48 mld. | |
+2,36% | 26,25 mld. | |
+12,96% | 24,62 mld. |